JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 18, 2024
JW THERAP-B: PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
JW THERAP-B: 2023 Environmental, Social and Governance Report
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
JW THERAP-B: Next Day Disclosure Return
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
JW THERAP-B: Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
JW THERAP-B: Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NMPA ACCEPTANCE OF THE SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION FOR CARTEYVA IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC.
JW THERAP-B: RESIGNATION OF CHIEF FINANCIAL OFFICER
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
JW THERAP-B: Notification Letter and Change Request Form to Registered Holders
JW THERAP-B: Notification Letter and Request Form to Non-registered Holders
JW THERAP-B: VOLUNTARY ANNOUNCEMENT - POTENTIAL FURTHER STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC.
JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
No Data